Skip to main content

Advertisement

SpringerLink
Log in

Ghrelin and Obestatin Levels in Type 2 Diabetic Patients With and Without Delayed Gastric Emptying

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Alterations in the neurohumoral regulation of the upper intestine may change rhythmicity and pattern of ghrelin and obestatin, the latter presumably antagonizing ghrelin effects. Five nongastroparetic diabetic patients and five with gastroparesis were investigated. Over 390 min including breakfast and lunch, ghrelin was significantly lower in patients with gastroparesis compared with in those without (P = 0.015). Ghrelin subsequent to lunch decreased significantly (P = 0.011) in patients without gastroparesis, but not in gastroparetic patients (P = 0.669). Obestatin was similar in both groups and unchanged. No significant differences in ghrelin-to-obestatin ratio were observed (P = 0.530). Loss of rhythmicity in the ghrelin levels of gastroparetic diabetics highlights the importance of integrity of the neurohumoral-intestinal axis. Stable diurnal obestatin levels do not support the concept of interaction between ghrelin and obestatin in terms of regulation of food intake and gastric emptying.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–1630.

    Article  PubMed  Google Scholar 

  2. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing alcylated peptide is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–4261. doi:10.1210/en.141.11.4255.

    Article  PubMed  CAS  Google Scholar 

  3. Korbonits M, Grossman AB. Ghrelin: update on a novel hormonal system. Eur J Endocrinol. 2004;151(Suppl 1):S67–S70. doi:10.1530/eje.0.151S067.

    Article  PubMed  CAS  Google Scholar 

  4. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210–215. doi:10.1002/bjs.5227.

    Article  PubMed  CAS  Google Scholar 

  5. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf). 2008;69(2):173–179.

    Article  CAS  Google Scholar 

  6. DeBlock CEM, De Leeuw IH, Pelckmans PA, Callens D, Maday E, Van Gaal LF. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care. 2002;25:912–917. doi:10.2337/diacare.25.5.912.

    Article  Google Scholar 

  7. Feldmann M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98:378–384.

    Google Scholar 

  8. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science. 2005;310:996–999.

    Article  PubMed  CAS  Google Scholar 

  9. de Smet B, Thijs T, Peeters TL, Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil. 2007;19:211–217. doi:10.1111/j.1365-2982.2006.00883.x.

    Article  PubMed  Google Scholar 

  10. Bassil AK, Haglund Y, Brown J, et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol. 2007;150:58–64. doi:10.1038/sj.bjp.0706969.

    Article  PubMed  CAS  Google Scholar 

  11. Qiu WC, Wang ZG, Wang WG, et al. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis. World J Gastroenterol. 2008;14:1419–1424. doi:10.3748/wjg.14.1419.

    Article  PubMed  CAS  Google Scholar 

  12. Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab. 2007;92:1875–1880. doi:10.1210/jc.2006-2306.

    Article  PubMed  CAS  Google Scholar 

  13. Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes. 2005;54:1371–1378. doi:10.2337/diabetes.54.5.1371.

    Article  PubMed  CAS  Google Scholar 

  14. Gaddipati KV, Simonian HP, Kresge KM, Boden GH, Parkman HP. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci. 2006;51:1339–1346. doi:10.1007/s10620-005-9022-z.

    Article  PubMed  CAS  Google Scholar 

  15. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008;36:44–54. doi:10.2967/jnmt.107.048116.

    Article  PubMed  Google Scholar 

  16. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: Three pieces of the same puzzle. Peptides. 2008;29:1255–1270. doi:10.1016/j.peptides.2008.02.018.

    Article  PubMed  CAS  Google Scholar 

  17. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337–345. doi:10.1053/gast.2001.22158.

    Article  PubMed  CAS  Google Scholar 

  18. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab. 2006;91:3296–3302. doi:10.1210/jc.2005-2638.

    Article  PubMed  CAS  Google Scholar 

  19. Ueno H, Shiiya T, Mizuta M, Mondal SM, Nakazato M. Plasma ghrelin concentrations in different clinical stages of diabetic complications and glycemic control in Japanese diabetics. Endocr J. 2007;54:895–902. doi:10.1507/endocrj.K07-007.

    Article  PubMed  CAS  Google Scholar 

  20. Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341–3350. doi:10.1210/en.2002-220225.

    Article  PubMed  CAS  Google Scholar 

  21. Zamrazilová H, Hainer V, Sedláčková D, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res. 2008;57(Suppl 1):S49–S55.

    PubMed  Google Scholar 

  22. Anderwald-Stadler M, Krebs M, Promintzer M, et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab. 2007;293:E1393–E1398.

    Article  PubMed  CAS  Google Scholar 

  23. Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes. 2008;57(4):967–979.

    Article  PubMed  CAS  Google Scholar 

  24. Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neurosci Lett. 2006;404:222–226. doi:10.1016/j.neulet.2006.05.053.

    Article  PubMed  CAS  Google Scholar 

  25. Carlini VP, Schiöth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun. 2007;352:907–912. doi:10.1016/j.bbrc.2006.11.112.

    Article  PubMed  CAS  Google Scholar 

  26. Camina JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol. 2007;211:1–9. doi:10.1002/jcp.20925.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine 1, Division of Endocrinology and Metabolism, Friedrich-Alexander University Erlangen-Nuremberg, Ulmenweg 18, 91054, Erlangen, Germany

    Igor A. Harsch

  2. Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA, USA

    Corinna Koebnick

  3. Department of Surgery, Klinikum Lippe-Detmold, 32756, Detmold, Germany

    Atingwa M. Tasi

  4. Department of Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg, Ulmenweg 18, 91054, Erlangen, Germany

    Eckhart Georg Hahn & Peter C. Konturek

Authors
  1. Igor A. Harsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Corinna Koebnick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atingwa M. Tasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eckhart Georg Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter C. Konturek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Igor A. Harsch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harsch, I.A., Koebnick, C., Tasi, A.M. et al. Ghrelin and Obestatin Levels in Type 2 Diabetic Patients With and Without Delayed Gastric Emptying. Dig Dis Sci 54, 2161–2166 (2009). https://doi.org/10.1007/s10620-008-0622-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0622-2

Keywords

Search

Navigation